Edition:
United States

Antares Pharma Inc (ATRS.OQ)

ATRS.OQ on NASDAQ Stock Exchange Capital Market

2.76USD
3:44pm EDT
Change (% chg)

$-0.01 (-0.36%)
Prev Close
$2.77
Open
$2.72
Day's High
$2.80
Day's Low
$2.72
Volume
180,414
Avg. Vol
195,576
52-wk High
$2.89
52-wk Low
$0.70

ATRS.OQ

Chart for ATRS.OQ

About

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs.... (more)
No analyst recommendations are available for ATRS.OQ.

Overall

Beta: 0.28
Market Cap(Mil.): €395.82
Shares Outstanding(Mil.): 155.24
Dividend: --
Yield (%): --

Financials

  ATRS.OQ Industry Sector
P/E (TTM): -- 33.86 29.98
EPS (TTM): -3.18 -- --
ROI: -- 12.76 13.08
ROE: -- 14.82 14.23

BRIEF-Antares Pharma Q4 loss per share $0.03

* Antares pharma reports fourth quarter and full year 2016 operating and financial results

Mar 14 2017

BRIEF-Antares Pharma reported a preliminary net loss per share of $0.03

* Antares Pharma Inc - company reported preliminary total revenue of $14.2 million and $52.2 million for quarter and year ended december 31, 2016, respectively

Mar 06 2017

BRIEF-Antares Pharma announces FDA acceptance of new drug application for Quickshot testosterone

* Antares Pharma announces FDA acceptance of new drug application for Quickshot testosterone Source text for Eikon: Further company coverage:

Feb 27 2017

BRIEF-Antares Pharma reports Q3 financial and operating results

* Q3 earnings per share view $-0.03, revenue view $11.2 million -- Thomson Reuters I/B/E/S

Nov 09 2016

More From Around the Web

Earnings vs. Estimates

No consensus analysis data available.